Caution in interpreting tralokinumab outcomes in dupilumab nonresponders
Journal of the American Academy of Dermatology · 2026-08
DOI: 10.1016/j.jaad.2026.06.150 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the American Academy of Dermatology, 2026-08. Verfasst von Ercan Yılmaz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Allergy and Immunology Department, Faculty of Medicine, Inonu University, Malatya, Turkey. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Allergy and Immunology Department, Faculty of Medicine, Inonu University, Malatya, Turkey.
- Pediatric Allergy and Immunology Department, Faculty of Medicine, Inonu University, Malatya, Turkey. Electronic address: erdemtopal44@gmail.com.
- Department of Dermatology, Faculty of Medicine, Inonu University, Malatya, Turkey.
Zitieren
APA
Yılmaz, E., Topal, E., & Turkmen, D. (2026). Caution in interpreting tralokinumab outcomes in dupilumab nonresponders. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.06.150
Vancouver
Yılmaz E, Topal E, Turkmen D. Caution in interpreting tralokinumab outcomes in dupilumab nonresponders. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.06.150
BibTeX
@article{Ylmaz2026,
author = {Yılmaz, Ercan and Topal, Erdem and Turkmen, Dursun},
title = {Caution in interpreting tralokinumab outcomes in dupilumab nonresponders},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
doi = {10.1016/j.jaad.2026.06.150}
}
EUVIMED